Advances in systemic therapies for triple negative breast cancer.
Leon-Ferre RA, Goetz MP.
BMJ. 2023 May 30;381:e071674. doi: 10.1136/bmj-2022-071674.
Immunosurveillance in clinical cancer management.
Kroemer G, Chan TA, Eggermont AMM, Galluzzi L.
CA Cancer J Clin. 2024 Mar-Apr;74(2):187-202. doi: 10.3322/caac.21818. Epub 2023 Oct 25.
Preoperative and Postoperative Systemic Therapy for Operable Non-Small-Cell Lung Cancer.
Chaft JE, Shyr Y, Sepesi B, Forde PM.
J Clin Oncol. 2022 Feb 20;40(6):546-555. doi: 10.1200/JCO.21.01589. Epub 2022 Jan 5.
Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study.
Lordick F, Mauer ME, Stocker G, Cella CA, Ben-Aharon I, Piessen G, Wyrwicz L, Al-Haidari G, Fleitas-Kanonnikoff T, Boige V, Lordick Obermannová R, Martens UM, Gomez-Martin C, Thuss-Patience P, Arrazubi V, Avallone A, Shiu KK, Artru P, Brenner B, Buges Sanchez C, Chau I, Lorenzen S, Daum S, Sinn M, Merelli B, van Grieken NCT, Nilsson M, Collienne M, Giraut A, Smyth E.
Ann Oncol. 2025 Feb;36(2):197-207. doi: 10.1016/j.annonc.2024.10.829. Epub 2024 Nov 13.
Neoadjuvant PD-1/PD-L1 Inhibitors for Resectable Head and Neck Cancer: A Systematic Review and Meta-analysis.
Masarwy R, Kampel L, Horowitz G, Gutfeld O, Muhanna N.
JAMA Otolaryngol Head Neck Surg. 2021 Oct 1;147(10):871-878. doi: 10.1001/jamaoto.2021.2191.
The role of immunotherapy in the treatment of colorectal cancer.
Orhan A, Mørup S, Poulsen LØ, Pfeiffer P, Qvortrup C, Gögenur I.
Ugeskr Laeger. 2023 Dec 18;185(51):V06230371.
Symptoms of arteria spinalis anterior syndrome in a patient with ischaemic stroke and Takayasu arteritis.
Ravn NH, Havsteen I, Eiberg JP, Meden P.
Ugeskr Laeger. 2023 Dec 18;185(51):V07230447.
Preoperative immunotherapy for head and neck cancers: state of art.
Egloff AM, Uppaluri R.
Curr Opin Oncol. 2022 May 1;34(3):185-195. doi: 10.1097/CCO.0000000000000826. Epub 2022 Mar 7.
A spatiotemporal comparative analysis on tumor immune microenvironment characteristics between neoadjuvant chemotherapy and preoperative immunotherapy for ESCC.
Zhou Z, Zhang H, Du J, Yang J, Pan W, Zhang Q, Wang H, Tang P, Ba Y, Zhang H.
Cell Death Dis. 2024 Sep 10;15(9):663. doi: 10.1038/s41419-024-06986-y.
TREM2 scFv-Engineering Escherichia coli Displaying Modulation of Macrophages to Boost Cancer Radio-Immunotherapy.
Wang Y, Dong A, Man J, Chen H, Shen W, Wang L, Yang H, Hu L, Yang K.
Adv Mater. 2025 May;37(19):e2417920. doi: 10.1002/adma.202417920. Epub 2025 Mar 19.
